Investment Highlights- Player at the Frontline of the Booming Cobot Industry- Robust Research and Development Capabilities Guided by a Long-termist Mindset- Proprietary Full-stack Technologies Covering All the Key Aspects in the Cobot Development Cycle- Comprehensive Product Matrix Catering to a Wide Array of Use Cases- Successful Commercialization Underscored by Global Footprint and Clientele- Visionary and Experienced Management TeamHONG KONG, Dec 13, 2024 - (ACN Newswire via SeaPRwire.com) - SHENZHEN DOBOT CORP LTD (“DOBOT” or the “Company”, together with its subsidiaries, collectively referred as the “Group”) has recently announced the details of the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEx”) (the “Share Offer”).DOBOT plans to offer a total of 40,000,000 shares, subject to over-allotment option, comprising 2,000,000 Public Offer Shares and 38,000,000 Placing Shares, at an Offer Price range between HK$18.80 and HK$20.80 per Offer Share. The Public Offer opened at 9:00 a.m. on Friday, December 13 and close at 12:00 noon on Wednesday,December 18. The allotment results will be announced on Friday, December 20. Dealings in H shares on HKEx are expected to commence on Monday, December 23, under the stock code 2432.HK.Guotai Junan Capital Limited and ABCI Capital Limited are the Joint Sponsors. Joint Bookrunners are Guotai Junan Securities (Hong Kong) Limited, ABCI Capital Limited, China PA Securities (Hong Kong) Company Limited,Shenwan Hongyuan Securities (H.K.) Limited and TradeGo Markets Limited.Company OverviewDOBOT is one of leading companies that specializes in the development, manufacturing and commercialization of collaborative robots, or commonly known as“cobots.” DOBOT is a top 2 player in the global cobot industry and the No.1 player among all Chinese cobot companies, with a global market share of 13.0% as measured by shipment volume in 2023, according to the CIC Report. The global cobot industry is at a nascent stage of development, whose market size accounted for less than 2% of the global robot industry in terms of revenue in 2023. According to the same source, the Group ranked seventh in the global cobot industry with a global market share of 3.6% in terms of global revenue generated from cobots in 2023.The Group is focusing on industry innovation, particularly in cobot safety measures and AI capabilities, by introducing the flexible e-skin technology, SafeSkin, and launching AI-empowered cobots underpinned by its AI cobot empowering platform, X-Trainer. As of 6 December 2024, the Group offered a total of 27 cobot models in four series, catering to numerous use cases in manufacturing, retail, healthcare, STEAM education, scientific research settings and many more. During the Track Record Period, the Group sold a total of over 53,000 cobots globally.Business Model and Market OutlookCobots are robots with operational robotic arms intended for direct human-robot interaction or collaboration within a shared space or where humans and robots are operating in proximity. DOBOT is primarily engaged in the design,development, manufacturing and commercialization of cobots. Its cobot products are adopted by global customers for various use cases in manufacturing, retail, healthcare, STEAM education, scientific research settings and many more. All of the cobot products are designated Specialist Technology Products. The Group adopted a transaction[1] based model for the sales of the cobot products.The global cobot market size has grown significantly from US$466.6 million in 2019 to US$1,039.5 million in 2023,at a CAGR of 22.2%, and is expected to reach US$4,950.0 million by 2028, at a CAGR of 36.6% from 2023 to 2028.In particular, China is playing an increasingly important role in the global cobot market, with its share in the global cobot market projected to increase from 26.3% in 2023 to 37.2% in 2028, at a CAGR of 46.5% from 2023 to 2028.The proliferation of AI technologies is expected to further accelerate the adoption of cobots in more use cases. The Group believes DOBOT is well positioned to capture the substantial market opportunity.Financial HighlightsThe total revenue of the Group was approximately RMB174.3 million, RMB241.0 million, RMB286.7 million for FY2021, FY2022, FY2023, respectively, at a CAGR of 28.3% and increased by 9.6% from RMB109.9 million in the six months ended June 30, 2023 to RMB120.5 million in the six months ended June 30, 2024. The Group’s export volume of cobots has consistently ranked first in China for six consecutive years, according to the CIC Report.The Group recorded gross profit of RMB88.1 million, RMB98.2 million, RMB124.8 million, and RMB52.8 million in 2021, 2022, 2023 and the six months ended June 30, 2024, respectively. The gross profit margin in 2021, 2022 and 2023 was 50.5%, 40.8%, 43.5% and 43.9%, significantly above the industry average. The outstanding margin profile is largely attributable to the global distribution network and an international clientele. In 2021, 2022, 2023 and the six months ended June 30, 2024, overseas markets contributed 48.1%, 58.1%, 59.1% and 61.4% of the total revenue, respectively. The cost advantages also stem from the proprietary development of key components and in-house design and development of key components as well as economies of scale as demands for the products continue to grow, coupled with the ongoing ramp-up of the production base in Rizhao, Shandong. Being a major port city, Rizhao’s proximity to the port significantly reduces transportation costs, facilitating efficient global export of the products. The favorable margin profile not only improves the financial performance but also affords us more flexibility in marketing strategy tailored to an increasingly competitive landscape.In 2021, 2022 and 2023, the Group had losses for the year of RMB41.8 million, RMB52.5 million and RMB103.3 million, respectively, and in the six months ended June 30, 2023 and 2024, the Group had losses for the period of RMB51.7 million and RMB59.9 million, respectively. This mainly attributes to the fact that the Group is in the stage of expanding the Group’s business and operations in the rapidly growing cobot market and are continuously investing in research and development.Competitive StrengthsAs one of the leading companies in the cobot industry, the Group believes that its success is attributable to the following competitive strengths: Firstly, DOBOT is one of the leading players at the frontline of the booming cobot industry, which has been recognized by world-renowned customers for its outstanding technical capabilities and product strength, and has led to a number of advance technological innovations, especially in cobot safety measures and AI capabilities. At the same time, the Group adheres to the long-termist mindset and guides its product R&D, and the Group's research and development initiatives are geared towards sustainable growth and enduring impact. Leveraging its interdisciplinary research and development capabilities, the Group has become one of few in the global cobot industry, according to the CIC Report, that have developed proprietary full-stack technologies that cover all the key aspects in the cobot development cycle. In addition, the Group has a comprehensive product matrix catering to a wide array of use cases; More importantly, under the leadership of its experienced management team, the Group continues to expand its market share through the successful commercialization of its global business and customers.Growth StrategiesIn future, the Group pursues the following strategies to further grow the business: (1) continue to advance technology development, including further investing in the research and development of proprietary key components of cobots, investing in the research and development of AI technologies, further improving its motion control algorithms, and building a full-perception technology architecture to expand the perception and interaction capabilities of our cobots and continue to enhance the safety measures in human-robot collaboration to meet the requirements in various use cases; (2) continue to expand the Group’s product offering and ecosystem to maintain its competitive edge in comprehensive product offerings by further upgrading existing products and launching new products; (3) enhance production capabilities and capacity to streamline supply chain management by introducing advanced manufacturing technologies and equipment to the production lines; (4) further fortify the Group’s sales network to expand global reach. The Group plans to establish three overseas subsidiaries in Thailand, Mexico and United Arab Emirates to seize the business opportunities; and (5) selectively pursue strategic collaboration, investment and acquisition opportunities to integrate industry resources that may help the Group acquires new technologies, expand sales channels and tap into new industries where most of potential customers have their designated cobot integrators or suppliers.Mr. Liu Peichao, Founder, Controlling Shareholder, Chairman of the Group’s Board, executive Director and general manager of DOBOT concluded, “We are pleased to witness this significant milestone in the Group’s history.Through the Group’s listing on the Main Board of HKEx, we will tap into the international capital markets. This will not only broaden the Group’s capital and shareholder base, but will also provide us with capital to fund the Group’s expansion plan, which will finally strengthen the Group’s position in the industry and further enhance the Group’s competitive advantages, thereby driving the Group’s long-term development.”"Looking ahead, we are committed to further developing and consolidating the Group’s position in the collaborative robotics industry. The growth rate of the global collaborative robot industry will far exceed the growth rate of the traditional industrial robot industry. It is expected that the popularization of AI technology will further accelerate the adoption of cobots in more use cases. With considerable growth and the Group’s own full-stack technology, we look forward to capturing the global cobot market opportunity to maintain our leading position in the industry and create greater value for the shareholders."For further enquiries, please contact Bright Communications International Limited:Ms. Kung Mobile: (852) 46371627Email: ir@brightcommns.com Copyright 2024 ACN Newswire via SeaPRwire.com.

Fosun Bolsters Core Business with Two Key Asset Privatizations

December 13, 2024

HONG KONG, Dec 13, 2024 - (ACN Newswire via SeaPRwire.com) - On the evening of 10 December, Fosun Tourism Group (FTG) announced on the Hong Kong Stock Exchange its plan to repurchase shares at a price of HK$7.8 per share. This price represents a 111% premium over the closing price of the day before the last trading day. This privatization will raise FTG’s market value to HK$10.5 billion, and the announcement swiftly captured widespread attention.The market generally perceives this move as part of Fosun’s strategy to focus on its core businesses and consolidate resources to support its core industries with established advantages. In June, Fosun Pharma announced its plan to privatize its biopharmaceutical subsidiary, Shanghai Henlius, through a merger.Within a year, with two key subsidiaries announced for privatization, what strategy is Fosun pursuing? Analysts suggest that “These two subsidiaries are high-quality assets of Fosun, and their privatization reflects Fosun’s commitment to strengthening its focus on core businesses with established advantages. This move also indicates that Fosun has ample cash flow, enabling it to pursue sustainable growth and make flexible adjustments.”Recently, Fosun has been active in its core sectors, such as tourism and pharmaceuticals. The company recently co-organized a biopharmaceutical innovation forum and signed agreements with several high-profile institutions. It also shipped its independently-developed drug, HANQUYOU, to the U.S. and expanded Club Med into the Greater Bay Area. These actions demonstrate Fosun’s intention to focus on its core businesses, building momentum for high-quality growth.Focusing on asset-light operations to create long-term value through a “retreat to advance” strategy in the tourism sectorSince the trading halt of FTG on 27 November, speculation about its privatization has circulated widely in the market. The announcement on 10 December confirmed FTG’s privatization, with investors noting that the privatization is a win-win choice.According to public information, FTG has been a core subsidiary within Fosun’s Happiness business segment since its establishment. In the first half of 2024, it reported a business volume of RMB10.65 billion, with an adjusted EBITDA of RMB2.09 billion and a profit attributable to equity holders of the company of RMB320 million, reflecting a 20% increase compared to the same period in 2023, excluding the one-off gain on disposal of resorts.In recent years, FTG has faced challenges due to global macroeconomic environment, trends in the tourism industry, and the overall performance of the Hong Kong stock market. Since its listing, the company’s share price has not reflected its true value, and trading volumes have been low, limiting its financing capacity. The advantages of being a listed company have not been fully realized, while maintaining its listing status has incurred additional costs. Completing the privatization will not only resolve liquidity issues but also enhance strategic flexibility and focus on long-term sustainable development.As a flagship brand of FTG, Club Med has recently achieved a new breakthrough. On 29 November, Shenzhen, CITIC, and Fosun signed a cooperation framework agreement to launch Club Med at Jinsha Bay in Dapeng New District, a key area for tourism development in Shenzhen. This collaboration is viewed in the tourism industry as a powerful alliance, combining high-quality resources.Club Med Joyview, the product line set to debut in Jinsha Bay, is designed specifically for the Chinese market, focusing on urban short-distance vacations. It has already seen success in locations such as Qiandao Lake in Zhejiang and Heilongtan in Sichuan. Dapeng New District holds high hopes for the project, believing that the establishment of a Club Med resort in Jinsha Bay will “fill a gap in high-end family resorts in Shenzhen and enhance the international profile and tourism appeal of both Shenzhen and Dapeng New District.”Analysts noted that Fosun is increasingly strengthening its asset-light strategy in the tourism sector. By leveraging strong intellectual properties and operational capabilities, Fosun has been accelerating partnerships with local governments and state-owned enterprises to seize promising projects. In addition to launching Club Med in Jinsha Bay, the recent signing of the second phase of the Taicang Alps Resort and the launch of the ULTRAMED Hainan are also prime examples of this asset-light approach.“At first glance, Fosun’s move towards privatization may seem like a ‘retreat’. However, the clear strategic direction and the steady advancement of asset-light projects indicate that the company is actually ‘retreating to advance’. In an uncertain market cycle, this approach maximizes strategic flexibility, allowing a focus on long-term goals and sustainable development.”Strengthening the pharmaceutical sector and embracing integrated innovation with a global perspectiveIn addition to the tourism sector, pharmaceuticals continue to be a key pillar of Fosun’s business profile, with the company making significant strides in this area recently.On 2-3 December, Fosun co-organized the first “Greater Bay Area (GBA) Star” Biopharmaceutical Original Innovation Forum in Shenzhen. Just two weeks prior, it co-organized another forum themed on “Original Innovation” in Shanghai.By co-organizing two high-profile industry forums within a month, Fosun has demonstrated its leadership and influence in the biopharmaceutical field. Fosun also signed strategic cooperation agreements with Fudan University, Shanghai University, the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Ruijin Hospital, among others, to jointly promote original innovation.Guo Guangchang, Chairman of Fosun International, said at the forum, “Good innovation must start from demand. In the biopharmaceutical sector, this means putting ‘patients first’. Additionally, innovation should maintain a ‘global perspective’, always embracing an open mindset and adhering to a win-win cooperation.”While driving innovation in the industry, Fosun has also made important breakthroughs in broaden its global market reach. On 29 November, the first batch of HANQUYOU, a trastuzumab biosimilar independently developed and manufactured by Shanghai Henlius, was shipped to the U.S.HANQUYOU is the first China-developed monoclonal antibody biosimilar approved in China, the EU, and the U.S. To date, it has been approved in 50 countries and regions, benefiting over 220,000 HER2-positive breast and gastric cancer patients globally. According to Shanghai Henlius, approximately 6.5 million units of HANQUYOU have been shipped globally since its commercialization in 2020. In 2023 alone, HANQUYOU contributed over RMB2.7 billion in sales revenue.Industry expert believes that successfully entering the U.S. market will significantly enhance the growth trajectory of HANQUYOU and lay a solid foundation for the overseas expansion of Shanghai Henlius’ products. “The reasoning is simple: by breaking into the toughest market, the company gains confidence when approaching other countries and regions.”After more than a decade of development, Shanghai Henlius has built a diversified and robust product pipeline encompassing over 50 molecules, covering areas such as oncology, autoimmune diseases, and ophthalmology. Currently, 6 products have been approved for marketing in China, 3 have been approved for marketing in overseas markets, and 24 indications have received approval, and 4 applications have been accepted by the National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA) in the EU. In addition to HANQUYOU, products such as HANSIZHUANG, HANLIKANG, HANDAYUAN, and HANBEITAI maintain leading positions in their respective markets.Notably, in June, Fosun Pharma announced its plans to privatize its subsidiary, Shanghai Henlius, through a merger. The proposed purchase price is HK$24.6 per share, representing a premium of 36.67% over the closing price on the Hong Kong Stock Exchange on the undisturbed date, and a premium of 52.04% over the average closing price based on the daily closing prices of H Shares as quoted on the Hong Kong Stock Exchange for the 30 trading days immediately prior to and including the undisturbed date. The total cash consideration shall not exceed HK$5.407 billion. Following this announcement, Fosun Pharma’s share price surged significantly.The industry generally views this privatization as a way for Shanghai Henlius to implement its long-term strategy more flexibly, which will help avoid the pressures of market expectations and stock price volatility associated with being publicly listed. This move also allows for a fresh start, enabling the company to explore new development opportunities through asset restructuring and industry adjustments. Once privatized, Shanghai Henlius’ core capabilities and long-term value will be further realized, thereby enhancing Fosun’s competitive edge in the pharmaceutical sector.Strong financial position and ample cash flow recognized by domestic and international institutionsFrom a financial perspective, Fosun’s recent series of strategic moves reflects its solid financial standing and ample cash flow, enabling it to pursue various strategies, including privatization.As of 30 June 2024, the company’s cash, bank balances and term deposits reached RMB109.55 billion, representing an increase of approximately RMB17.1 billion since the end of 2023.Recently, S&P and securities firms such as CITIC, have released reports highly recognizing Fosun’s focus on its core businesses in the household consumption sector, its optimization of asset structure, and its successful U.S. dollar note issuance to broaden its funding channels. Several securities firms have assigned Fosun a “Buy” rating.S&P believes Fosun has adequate liquidity buffer to meet its debt maturities obligation over the next two years and expects Fosun to continue divesting its non-core assets, leading to a steady decline in its debt. Furthermore, as offshore subsidiaries reach maturity, Fosun International’s dividend receipts are expected to enhance significantly. Therefore, S&P maintained a “stable” rating outlook on Fosun International.CITIC Securities noted that since 2020, Fosun has focused on developing strategically core businesses with market leadership while optimizing its asset structure and financial position through the divestment of non-strategy and non-core assets. As the company deepens its global operations, enhances business synergies, and improves its technological innovation capabilities, it is poised to unlock long-term growth potential.Analysts expressed that with strong financial backing, Fosun is continuously enhancing its competitiveness by focusing on its core sectors and exploring new growth opportunities, thereby further releasing its long-term value. Copyright 2024 ACN Newswire via SeaPRwire.com.

SeaPRwire

MTT Sports Unveils Road Map for Its World-Class E-Sports Tournament Platform

JCN Newswire

Notification of Dissolution of Joint Management of LT Metal Co., Ltd. by TANAKA Kikinzoku Kogyo K.K. and LT Corp.

December 12, 2024

TOKYO, Dec 13, 2024 - (JCN Newswire via SeaPRwire.com) - TANAKA Kikinzoku Kogyo K.K. (Head office: Chuo-ku, Tokyo; CEO: Koichiro Tanaka), which develops industrial precious metal products as one of the core companies of TANAKA Precious Metals, has announced the dissolution of joint management of LT Metal Co., Ltd. (Head office: Seo-gu, Incheon, Korea; CEO: SEOG-HO RO), the joint venture with LT Corp. in Korea, as set forth below. TANAKA Kikinzoku Kogyo K.K. (hereinafter referred to as the “Company”) had been jointly managing LT Metal Co, Ltd. (formerly named Heesung Metal Co., Ltd.), a joint venture company engaging in manufacturing and sale of electrical contacts, brazing alloys, precious metal plating materials, and other products based on TANAKA Precious Metals’ technologies, with LT Group (formerly named Heesung Group), a member of LG Group in Korea, for 50 years since the founding of LT Metal Co, Ltd. in 1974. During that period, the Company had been comprehensively cooperating with LT Group in conducting precious metals-related business in Korea. Considering the changes in the business environment globally and in Korea, the Company reached an agreement with LT Corp. to dissolve the joint management of LT Metal Co., Ltd. and terminate non-competition with each other in order to expand business opportunities and pursue the growth of business. The Company will maintain a good relationship and cooperate with LT Group, especially in the precious metals plating business. About TANAKA Precious MetalsSince its foundation in 1885, TANAKA Precious Metals has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,355 employees, the group’s consolidated net sales for the fiscal year ending December 2023, was 611.1 billion yen.TANAKA Holdings Websitehttps://www.tanaka.co.jp/english/ Global industrial business website https://tanaka-preciousmetals.com/en/ LT Corp.Address: 13F, Orange Planet Bldg., 217, Teheran-ro, Gangnam-gu, Seoul, KoreaRepresentatives: BON SIK KOO and WOONG-MO KOOMain Businesses: Management of interests in subsidiaries and investee companies, and investmentFounded: 2023Net Sales: 431.5 billion won (Consolidated financial statements for 2023)Employees: 8 Website: www.ltholdings.co.kr LT Metal Co., Ltd.Address: 14, Gajaeul-ro, Seo-gu, Incheon, KoreaRepresentative: SEOG-HO ROMain Businesses: Electrical contacts, bonding wires, ITO targets, plating materials, and recovery and refiningFounded: 1974Net Sales: 823.6 billion won (2023)Employees: 503 Website: www.ltmetal.co.kr Press inquiriesTANAKA Holdings Co., Ltd.https://tanaka-preciousmetals.com/en/inquiries-for-media Press Release: https://www.acnnewswire.com/docs/doc/20241212_EN.pdf Copyright 2024 JCN Newswire via SeaPRwire.com.

教宗方濟各引用福音，表示應「歡迎」和「融合」移民 “`

December 12, 2024

(SeaPRwire) - 教宗方濟各援引福音，呼籲要「歡迎、鼓勵和融合」移民，此時歐洲和美國正努力應對前所未有的全球大規模移民潮。這位教宗一直以來都是尋求庇護者、難民和經濟移民的堅定擁護者，他表示許多移民面臨著「被迫遷徙的悲劇」，他們冒險經海路尋找更好的生活，有時甚至會導致悲劇。週三，他在向一個名為「ResQ」的意大利親移民非營利組織發言時表示，許多貧困移民在前往未知國度的旅途中經常遭受「剝削、拒絕、虐待和淪為奴隸」。他讚揚了像ResQ這樣的團體，該團體致力於保護地中海海域的難民和處於危險中的人。該組織擁有自己的長達128英尺的救援船，協助在海上拯救移民。「因此，我們歡迎那些不僅遠遠批評，而是積極參與、貢獻時間、智慧和資源來減輕移民痛苦、拯救他們、歡迎他們和融合他們的人的行動。」教宗方濟各說。「移民必須受到歡迎、陪伴、鼓勵和融合。這種慷慨，這種勤奮與福音相符，福音呼籲我們對每個人行善，尤其是對最後的、最貧窮的、最被遺棄的、生病的、處於危險中的人。」隨著居民和政府經常努力應對住房和餵養移民的成本與人道主義關切之間的衝突，這場危機深深地分裂了西方的意見。例如，紐約市在2023年和2024財年合計支出48.8億美元用於提供住所、食物和……教宗補充道：「面對移民現象的廣泛性和複雜性，民政當局並非總是能夠完全履行其責任。」教宗說：「的確，拯救那些在破舊船隻上瀕臨沉沒的人……是一項非常必要的任務。」「貴組織所採取的行動旨在拯救生命：那些逃離嚴重衝突地區的人的生命，這些衝突常常引發人道主義危機，並涉及侵犯基本人權。」「親愛的朋友們，繼續前進！願聖母，移民的幫助者，幫助你們的工作。我祝福你們，並以祈禱陪伴你們。」由於世界許多地區缺乏可比數據，難以獲得在整個危機期間離開原籍國的移民的確切人數。聯合國國際移民組織 (IOM) 估計，2023年有創紀錄的650萬移民移居經濟合作與發展組織 (OECD) 國家，比2022年增長了10%。根據《紐約時報》最近的一篇報導，援引國會預算辦公室的數據，拜登政府時期的淨移民總數可能超過800萬人。這場危機使聯邦、州和地方財政捉襟見肘。這並非教宗首次呼籲各國向移民開放邊境。在去年梵蒂岡的一次集會上，他讚揚了一項創建所謂「人道主義走廊」的倡議，以便難民能夠安全地前往歐洲。教宗方濟各說：「安全、有序、規範和可持續的移民符合所有國家的利益。」聖艾智德天主教慈善機構、福音教會聯合會和瓦爾登斯教會帶頭在意大利開展了這個由各教派參與的人道主義轉移倡議，從2016年到2023年，已有6000多人通過該倡議來到歐洲。根據該計劃，援助工作者在難民營中甄別尋求庇護者，並辦理初步文件，以便基於人道主義理由將他們帶到意大利。抵達後，他們將獲得協助以安頓下來並申請庇護。天主教會教導說，世俗政府在處理移民和尋求在其邊境內獲得難民身份的局外人時，有兩項需要平衡的義務。這些義務在……中作了概述，該文件是闡述教會關於神學和社會問題教義的權威文件。第一項義務是「出於慈善和對人的尊重的緣故歡迎外國人」，因為人「有移民的權利，因此政府必須在最大程度上，特別是財力雄厚的國家，滿足這種權利」。第二項義務，基於……的義務，是「為了公共利益保障自己的邊界和執行法律」。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

News

俄勒岡州全球最大聖誕樹農場年銷近百萬棵樹

December 12, 2024

(SeaPRwire) - 當然，聖誕樹一點也不缺根據世界人口評論，俄勒岡州是美國最大的聖誕樹生產州，每年收穫約400萬棵聖誕樹。根據國家環境資訊中心，這相當於美國每年生產的聖誕樹總量的約33%。根據該來源，這個數字相當於每年約1.2億美元。俄勒岡州擁有Holiday Tree Farms，這家農場被廣泛認為是世界上最大的聖誕樹生產商。根據全國聖誕樹協會的數據，該農場是美國15,000個種植聖誕樹的農場之一。 Holiday Tree Farms由舒德爾家族於1955年創立。根據Holiday Tree Farms網站的數據，該農場面積高達8,500英畝，每年從該地點收穫100萬棵樹。根據該網站的數據，在收穫季節，該農場的12個獨立加工場僱用了約600名員工。該農場種植了幾種在節日期間通常陳列在家中的不同種類的樹木，但最受歡迎的是它們的道格拉斯冷杉。Holiday Tree Farms種植的道格拉斯冷杉不僅銷售給俄勒岡州的居民；根據該農場網站的數據，它們還銷售到美國境外，並出口到墨西哥、關島、亞洲、中美洲等地。根據他們的網站，Holiday Tree Farms還種植大冷杉、高貴冷杉和諾德曼冷杉。就聖誕樹生產量而言，排在俄勒岡州之後的是……該州與俄勒岡州相差不大，每年生產約400萬棵樹，收入約8600萬美元，根據世界人口評論。根據全國聖誕樹協會的數據，美國每年銷售的真聖誕樹總數約為2500萬至3000萬棵，全國約有3.5億棵聖誕樹正在生長。種植聖誕樹的過程並非易事。根據該來源，對於一棵約六到七英尺高的普通大小的樹木來說，平均生長時間為七年，但生長時間可能長達15年。根據國家環境資訊中心，每年春天，全國各地的農民都會在秋季為節日收穫的每一棵樹的位子上種植一到三棵幼苗。從那裡開始，新種植樹木的緩慢生長過程就開始了。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

News

數百輛拖拉機堵塞倫敦市中心街道，農民抗議稅收變革

December 12, 2024

(SeaPRwire) - 數百輛拖拉機週三封鎖倫敦市中心的街道，這是農民對政府取消農業家庭繼承稅豁免後發起的最新抗議活動。這項措施被批評者稱為「拖拉機稅」，政府推出該措施以增加資金，用於支付緊張的公共服務費用，但農民表示，這將摧毀家族農場並減少糧食生產。週三，農民們將他們的拖拉機停放在議會大廈附近，希望能說服政府改變方針，否則將面臨不斷升級的抗議活動。「這是壓垮我們的最後一根稻草，」農民加雷斯·溫·瓊斯（Gareth Wyn Jones）站在一排停放的拖拉機前，抗議者舉著「沒有農民，就沒有食物，就沒有未來」的標語，對天空新聞（Sky News）說道。農民們表示，多年來，英國競爭激烈的超市行業、國外的廉價進口和脫歐後的補貼削減，壓縮了他們的收入。過去，世代相傳的農場可以免稅，但政府在10月份表示，農民將從2026年起繳納稅款。隨後，全國各地紛紛爆發抗議活動。最大規模的抗議活動發生在11月中旬，當時有13,000人聚集在西敏寺，其中包括英國最著名的農民傑里米·克拉克森（Jeremy Clarkson），這位前《Top Gear》節目主持人，他的節目《克拉克森農場》（Clarkson's Farm）是亞馬遜（Amazon）在英國最受歡迎的節目之一。政府一再表示，不會在繼承稅問題上改變主意。環境部長史蒂夫·里德（Steve Reed）表示，政府正在通過鄉村支援計劃來幫助農民。他在週三的一份聲明中表示：「我們致力於支持我們的農民，支持鄉村經濟增長和促進糧食生產。」根據新的繼承稅規則，從2026年起，將對超過100萬英鎊的農場價值徵收20%的稅款。現有的個人免稅額（已婚夫婦可以合併）將農場和相關資產的起徵點提高到300萬英鎊。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

News

參議員促拜登就將奧斯汀·泰斯從敘利亞遣返的努力向參議院通報

December 12, 2024

(SeaPRwire) - 獨家報導 - 在週三上午一次罕見的兩黨合作行動中，參議院兩黨議員呼籲拜登總統指示其政府在12月20日前向參議院通報正在進行的遣返奧斯汀·泰斯（Austin Tice）的努力。Digital 首先獲得的一封信，由參議員克羅寧（Cronyn）和馬里蘭州民主黨參議員克里斯·范·霍倫（Chris Van Hollen）共同致函白宮，呼籲拜登「把握」敘利亞迅速變化的局勢，確保泰斯的歸還。這封由34名參議員簽署的信中寫道：「鑑於阿薩德政權的近期垮台以及敘利亞局勢的變化，我們認為此時機是確保奧斯汀獲釋並把他送回家與家人團聚的關鍵時刻。」這封信讚揚了拜登和他的國家安全顧問傑克·沙利文（Jake Sullivan）發表聲明，確認泰斯的歸還是在叛軍接管大馬士革之際的「首要任務」，但國會議員希望獲得有關為確保其獲釋而採取的詳細步驟的簡報。多個獎勵系統已被啟動，包括提供高達100萬美元獎勵的系統，以及美國國務院的「正義獎勵」計劃，提供高達1000萬美元的獎勵，用於有關泰斯下落的線索。國務院發言人馬修·米勒（Matthew Miller）週一晚上告訴記者：「美國正在積極努力尋找奧斯汀·泰斯，並把他送回家與家人團聚。」與可能掌握泰斯下落線索的敘利亞當地消息來源聯繫的努力已經得到恢復。沙利文週一在美國廣播公司（ABC）的《早安美國》節目中表示，美國正在通過與可能掌握泰斯被關押監獄信息的敘利亞人士的秘密渠道溝通，與土耳其的合作夥伴合作，國務院證實，人質事務特使羅傑·卡斯滕斯（Roger Carstens）也在貝魯特採取了類似的接觸方式。阿薩德政權週日垮台，為泰斯的歸還帶來了新的希望。儘管泰斯於2012年在大馬士革被捕，其狀況不明，但他仍被評估為仍然在世，敘利亞臭名昭著的監獄中開始釋放被囚禁的男女老幼。「12年多來，奧斯汀的父母一直要求我們的政府把他接回家，鑑於敘利亞局勢的發展，我們敦促您抓住這個機會，立即努力確保奧斯汀獲釋。」克羅寧和范·霍倫撰寫的信中強調。「作為一位深受愛戴的兒子、兄弟、鷹級童軍、記者和退伍軍人，奧斯汀代表著我們國家所能提供的最佳品質，理應得到我們政府全力支持，以確保他獲釋。」「國會堅決且非常願意與您合作，把他送回他深愛的家人身邊。我們鼓勵您的政府利用一切可用手段，進一步阻止綁架美國公民的行為。」信中補充道。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

1 …466 467 468 469 470 … 574